Valuation: Balchem Corporation

Market Cap 5.35B 4.78B 4.44B 4.04B 7.63B 518B 7.67B 53.5B 20.96B 264B 20.09B 19.65B 847B P/E 2026 *
31.1x
P/E 2027 * 29.8x
Enterprise Value 5.39B 4.81B 4.47B 4.07B 7.68B 521B 7.72B 53.85B 21.1B 266B 20.22B 19.78B 853B EV / Sales 2026 *
4.76x
EV / Sales 2027 * 4.44x
Free-Float
99.51%
Yield 2026 *
0.7%
Yield 2027 * 0.78%
1 day-0.47%
1 week+0.76%
Current month+1.74%
1 month+0.70%
3 months+3.50%
6 months-4.06%
Current year+9.44%
1 week 164.12
Extreme 164.12
171.06
1 month 161.05
Extreme 161.0501
171.06
Current year 152.58
Extreme 152.58
183.9
1 year 140.7
Extreme 140.7
183.9
3 years 110.74
Extreme 110.74
186.03
5 years 110.15
Extreme 110.1456
186.03
10 years 67.71
Extreme 67.71
186.03
Manager TitleAgeSince
Chief Executive Officer 61 28/04/2015
Director of Finance/CFO 49 04/02/2019
Chief Tech/Sci/R&D Officer 56 01/10/2025
Director TitleAgeSince
Director/Board Member 63 16/09/2010
Chairman 61 01/01/2017
Director/Board Member 59 15/09/2015
Date Insider Type Main position Quantity % Market Cap. Importance
01/04/26 Other

Controller/Auditor

8,646 0.0270%
11/02/26 Free

Director

870 0.0027%
11/02/26 Free

Director

870 0.0027%
Change 5-day change 1-year change 3-year change Capi.($)
-0.47%+0.76%+16.03%+33.40% 5.35B
+0.05%+2.97%+3.58%+66.64% 79.01B
+0.91%+2.38%+2.96%+18.01% 38.22B
+1.73%-5.44%+1.55%-26.07% 33.56B
+0.84%+2.99%+5.92%+9.66% 31.96B
+1.68%+4.59%+8.69%+48.40% 30.37B
+0.32%+3.41%-3.22%+17.32% 25.88B
+2.24%+4.08%+55.94%+39.61% 24.41B
-0.95%-0.95%+56.76%+12.52% 18.26B
-1.87%+0.02%-41.20%-43.16% 17.56B
Average +0.45%+1.64%+10.70%+17.63% 30.46B
Weighted average by Cap. +0.61%+1.91%+8.48%+26.01%

Financials

2026 *2027 *
Net sales 1.13B 1.01B 940M 855M 1.61B 110B 1.62B 11.32B 4.43B 55.84B 4.25B 4.16B 179B 1.2B 1.07B 993M 904M 1.71B 116B 1.71B 11.96B 4.68B 59B 4.49B 4.39B 189B
Net income 175M 156M 145M 132M 249M 16.92B 251M 1.75B 685M 8.63B 657M 642M 27.69B 182M 163M 151M 138M 260M 17.64B 261M 1.82B 714M 8.99B 684M 669M 28.85B
Net Debt 35.51M 31.72M 29.5M 26.84M 50.67M 3.44B 50.89M 355M 139M 1.75B 133M 130M 5.62B -39.68M -35.44M -32.97M -29.98M -56.61M -3.84B -56.86M -397M -155M -1.96B -149M -146M -6.28B
Projected Income Statement - Annual - Balchem Corporation
Logo Balchem Corporation
Balchem Corporation develops, manufactures, distributes and markets specialty performance ingredients and products for nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition and industrial markets. Its segments include Human Nutrition and Health (HNH), Animal Nutrition and Health (ANH), and Specialty Products. The HNH segment provides human grade choline nutrients and mineral amino acid chelated products for nutrition and health applications. This segment also manufactures specialty vitamin K2, which plays a role in the human body for bone health, heart health and immunity, and methylsulfonylmethane (MSM). The ANH segment provides nutritional products derived from its microencapsulation and chelation technologies in addition to the nutrient choline chloride. The Specialty Products segment re-packages and distributes a number of gases and chemicals for various uses by its customers, notably ethylene oxide, propylene oxide, and ammonia.
Employees
1,379
Date Price Change Volume
09/10/26 $167.83 -0.47% 334,826
08/10/26 $168.63 +1.33% 211,019
07/10/26 $166.41 +0.68% 480,199
06/10/26 $165.29 -0.45% 165,888
05/10/26 $166.04 -0.31% 272,218
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
A
Ratings Surperformance© - Balchem Corporation
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
167.83USD
Average target price
209.25USD
Spread / Average Target
+24.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Balchem Corporation
  1. Stock Market
  2. Stocks
  3. BCPC Stock